Your browser doesn't support javascript.
loading
Multiplex immunoassay to measure antibody response to nine HPV vaccine types.
Panicker, G; Rajbhandari, I; Pathak, H N; Brady, A M; Unger, E R.
Affiliation
  • Panicker G; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, USA. Electronic address: dhv1@cdc.gov.
  • Rajbhandari I; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, USA.
  • Pathak HN; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, USA.
  • Brady AM; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, USA.
  • Unger ER; Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, USA.
J Immunol Methods ; 498: 113136, 2021 11.
Article in En | MEDLINE | ID: mdl-34464605
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunoglobulin G / Enzyme-Linked Immunosorbent Assay / Serologic Tests / Papillomavirus Vaccines / Immunogenicity, Vaccine / Antibodies, Viral Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunoglobulin G / Enzyme-Linked Immunosorbent Assay / Serologic Tests / Papillomavirus Vaccines / Immunogenicity, Vaccine / Antibodies, Viral Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Year: 2021 Type: Article